{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:54:35Z","timestamp":1772859275195,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Reactivation of cytomegalovirus (CMV) in CMV\u2010seropositive patients after haploidentical T\u2010cell receptor \u03b1\u03b2<jats:sup>+<\/jats:sup>\/CD19<jats:sup>+<\/jats:sup> depleted hematopoietic cell transplant (HCT) is common. Due to delayed CMV\u2010specific immune reconstitution, patients may require prolonged antiviral therapy, including secondary prophylaxis (SP). We present our clinical experience with the off\u2010label use of letermovir for SP in a severely immunocompromised 2\u2010year\u2010old toddler with refractory pre\u2010B\u2010cell ALL and bilateral retinitis caused by resistant CMV (A594V UL97 mutation) following a haploidentical TCR\u03b1\u03b2<jats:sup>+<\/jats:sup>\/CD19<jats:sup>+<\/jats:sup> depleted HCT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The patient underwent measurement of two separate sets of letermovir serum concentrations, drawn at pre\u2010dose, 1 and 4\u2009h (and 8\u2009h during the second therapeutic drug monitoring) post\u2010dose. Pharmacokinetic parameters, including AUC<jats:sub>0\u201324<\/jats:sub> were calculated, and dose adjustment was performed based on the drug level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>While receiving oral letermovir 240\u2009mg once daily without cyclosporine, the observed AUC<jats:sub>0\u201324<\/jats:sub> was high (75\u2009815\u2009ng\u2009h\/mL) with a <jats:italic>C<\/jats:italic><jats:sub>min<\/jats:sub> of 209\u2009ng\/mL. The dose was reduced by 25% to 180\u2009mg once daily. Despite the dose reduction, both AUC<jats:sub>0\u201324<\/jats:sub> and <jats:italic>C<\/jats:italic><jats:sub>min<\/jats:sub> values further increased to 119\u2009095\u2009ng\u2009h\/L and 959\u2009ng\/mL, respectively. The patient continued oral letermovir 180\u2009mg once daily for about 3\u2009months, with adequate viral suppression (CMV viral load in plasma &lt;150\u2009IU\/mL) and no recurrent CMV end\u2010organ disease or adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Given limited options for anti\u2010CMV therapy in young children with resistant CMV, letermovir could be considered as an alternative antiviral for SP. Further studies are warranted to evaluate the pharmacokinetics of letermovir in pediatric allogeneic HCT recipients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/petr.14580","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T10:53:00Z","timestamp":1689763980000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacokinetic analysis driven letermovir dosing in pediatric hematopoietic cell transplantation patients with resistant <scp>CMV<\/scp> disease"],"prefix":"10.1111","volume":"28","author":[{"given":"Vinita B.","family":"Pai","sequence":"first","affiliation":[{"name":"Nationwide Children's Hospital  Columbus Ohio USA"},{"name":"College of Pharmacy The Ohio State University  Columbus Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Tansmore","sequence":"additional","affiliation":[{"name":"Nationwide Children's Hospital  Columbus Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7907-957X","authenticated-orcid":false,"given":"Eunkyung","family":"Song","sequence":"additional","affiliation":[{"name":"Nationwide Children's Hospital  Columbus Ohio USA"},{"name":"College of Medicine The Ohio State University  Columbus Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-017-0180-z"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679639"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017012005"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13517"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1309533"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706640"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13187"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.01.027"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2022.01.002"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15848"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piac017"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.10.005"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz218"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piz033"},{"key":"e_1_2_9_16_1","unstructured":"Merck Sharp & Dohme LLC.Letermovir treatment in pediatric participants following allogeneic haematopoietic stem cell transplantation (HSCT) (MK\u20108228\u2010030). ClinicaTrials.gov identifier: NCT03940586. Updated January 11 2023. Accessed July 2 2023.https:\/\/www.clinicaltrials.gov\/study\/NCT03940586"},{"key":"e_1_2_9_17_1","unstructured":"Merck Sharp & Dohme LLC.A study of the drug letermovir as prevention of cytomegalovirus infection after stem cell transplant in pediatric patients.ClinicaTrials.govidentifier: NCT05711667. Updated March 17 2023. Accessed July 2 2023.https:\/\/www.clinicaltrials.gov\/study\/NCT05711667"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00657-22"},{"key":"e_1_2_9_19_1","unstructured":"RahwayN.PREVYMIS\u2122 (letermovir) Merck.https:\/\/www.merck.com\/product\/usa\/pi_circulars\/p\/prevymis\/prevymis_pi.pdf"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4016-1"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa135"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.431"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S180908"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13687"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/petr.14580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T06:19:18Z","timestamp":1724307558000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/petr.14580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1111\/petr.14580"],"URL":"https:\/\/doi.org\/10.1111\/petr.14580","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"2023-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14580"}}